Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Fish and Richardson
Teva
McKesson
McKinsey
Queensland Health
Baxter
Daiichi Sankyo
Dow

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006905

« Back to Dashboard

NDA 006905 describes NORISODRINE, which is a drug marketed by Abbvie and Abbott and is included in two NDAs. Additional details are available on the NORISODRINE profile page.

The generic ingredient in NORISODRINE is isoproterenol hydrochloride. There are sixteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
Summary for 006905
Tradename:NORISODRINE
Applicant:Abbvie
Ingredient:isoproterenol sulfate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:POWDER;INHALATIONStrength25%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:POWDER;INHALATIONStrength10%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
UBS
Moodys
Cipla
Accenture
Daiichi Sankyo
Fuji
Deloitte
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.